Compositions, kits and methods for treating benign prostate hyperplasia
TW201043221A
Kit and method for preparation of a Degarelix solution
EP2340812A1
Granules for pharmaceutical preparations, methods and apparatus for their production
WO2010022176A1
Methods of treatment for skeletal conditons
WO2010022171A1
Peptidic pth receptor agonists
WO2009150530A2
Pharmaceutical composition suitable for use as foam comprising 5'-aminosalicylic acid and silicone oil
TW200948378A
Pharmaceutical preparation
WO2009109584A1
ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
TW200938218A
Methods of treating prostate cancer with gnrh antagonist
NZ583899A
Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate
GB0805953D0
Process for the manufacture of a pharmaceutical product
CN101450049A
Pharmaceutical composition
CN101406457A
Process for the manufacture of a pharmaceutical product
GB0712626D0
Treatment and prevention of endometriosis using dopamine agonists.
DE102007015010A1
A system for containing and / or preparing an injectable product containing a liquid and a pharmaceutical composition
CA2584456A1
Composition comprising desmopressin
EP1952813A1
Medicament for the treatment of endometriosis
WO2007020508A1
Method and device for dividing granules
MX2007014022A
Use of antagonists of oxytocin and/or vasopressin in assisted reproduction.
CA2605972A1
Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
